e-learning
resources
London 2016
Monday, 05.09.2016
Prognostic variables in lung cancer II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interobserver variability of tumor proliferation index and the importance of semiautomated method for counting Ki-67 in lung carcinoma
Cristian Suciu (Timisoara, Romania), Cristian Suciu, Cristian Oancea, Ovidiu Burlacu, Remus Cornea, Oana Suciu, Marius Raica
Source:
International Congress 2016 – Prognostic variables in lung cancer II
Session:
Prognostic variables in lung cancer II
Session type:
Thematic Poster
Number:
2876
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cristian Suciu (Timisoara, Romania), Cristian Suciu, Cristian Oancea, Ovidiu Burlacu, Remus Cornea, Oana Suciu, Marius Raica. Interobserver variability of tumor proliferation index and the importance of semiautomated method for counting Ki-67 in lung carcinoma. Eur Respir J 2016; 48: Suppl. 60, 2876
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas
Source: Eur Respir J 2012; 40: 1221-1227
Year: 2012
The importance of Ki-67 proliferation index in small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Use of a semi-automatic human-supervised procedure for quantitative histology: Modulation of tumour cell dissemination in lung parenchyma
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Correlation of diffusion MRI with the Ki-67 index in non-small cell lung cancer
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Inter-reader variation in lung segmentation of functional lung MRI quantification.
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer
Source: Eur Respir J 2011; 37: 136-142
Year: 2011
Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma
Source: Eur Respir J 2013; 41: 943-951
Year: 2013
Quantitative prognostic markers for NSCLC: the state-of-the-art and methodology
Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014
Year: 2014
Visual emphysema evaluation on CT: Interobserver agreement and concordance with lung density and lung function
Source: International Congress 2014 – From lung imaging research to clinical use
Year: 2014
RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011
Attenuation change of lung nodules according to variation of examination techniques in low dose CT using iterative reconstruction: A phantom study
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA},
Source: Eur Respir J 2012; 40: 699-705
Year: 2012
The evaluation of bromodeoxyuridine labelling index in lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 86s
Year: 2006
Validation of CALIPER (Computer-aided lung informatics for pathology evaluation and rating) for the non-invasive assessment of pulmonary nodules of the adenocarcinoma spectrum
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Analysis of surgical stage lung cancer and tumour markers prognostic value
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006
Relative contribution of cytological specimen type in the determination of lung cancer histologic identity – Analysis of one year‘s comparative data
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept